This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ibex Biosciences, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations of Yuebin Tan in Gene Therapy
Introduction
Yuebin Tan is an accomplished inventor based in Cumberland, MD (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of hyperproliferative diseases. His innovative approaches aim to reduce tumor mass and inhibit cancer progression.
Latest Patents
Yuebin Tan holds a patent titled "Use of PCBP1 to treat hyperproliferative disease." This patent outlines compositions and methods that utilize gene therapy to decrease cell migration and metastasis. The methods involve the use of plasmids, vectors, and non-viral vectors containing PCBP1 and/or PCBP1 mutants. These innovations are designed to inhibit the expression of cancer biomarkers and effectively reduce tumor size.
Career Highlights
Yuebin Tan is currently associated with Ibex Biosciences, Inc., where he continues to advance his research in gene therapy. His work has the potential to significantly impact cancer treatment and improve patient outcomes.
Collaborations
Yuebin Tan collaborates with notable colleagues, including Norman Zhennan Lai and Michael Joseph Karlin. Their combined expertise enhances the research and development efforts at Ibex Biosciences, Inc.
Conclusion
Yuebin Tan's innovative work in gene therapy exemplifies the potential of scientific advancements in combating cancer. His contributions are paving the way for new treatment methodologies that could change the landscape of cancer care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile